RxDoctor Payments Data

Johanna Tarallo

Psychiatric/Mental Health · Syracuse, NYNPI 1164561536

Payments from drug & device makers

$6,370in general payments, 2019–2025

Across 312 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$976
  • Takeda Pharmaceuticals U.S.A., Inc.$841
  • Alkermes, Inc.$591
  • Lundbeck LLC$567
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$553
  • Teva Pharmaceuticals USA, Inc.$503
  • plus $2K from 10 others

What the payments were for

  • Food & beverage$6,32399%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,370 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole15$33,415
VraylarCariprazine Hcl24$33,355
EmsamSelegiline12$26,484
Bupropion XlBupropion Hcl44$992
Clonazepam87$858
Duloxetine Hcl38$822
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine23$747
Lamotrigine54$674
Sertraline Hcl39$556
Bupropion Hcl SrBupropion Hcl13$541
Alprazolam55$471
Escitalopram Oxalate29$363
Trazodone Hcl46$347
Aripiprazole13$326
Fluoxetine Hcl37$263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$375$33,41515 claims
AbbVieVraylar$976$33,35524 claims
Almatica Pharma LLCSertraline Hcl$217$55639 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →